Truist Financial
ATRC icon

Truist Financial’s AtriCure ATRC Stock Holding History

Truist Financial’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Buy
21,791
+246
+1% +$11.1K ﹤0.01% 1642
2026
Q2 		$603K Buy
21,545
+240
+1% +$6.75K ﹤0.01% 2083
2026
Q1 		$608K Buy
21,305
+111
+0.5% +$3.79K ﹤0.01% 1967
2025
Q4 		$838K Buy
21,194
+234
+1% +$8.58K ﹤0.01% 1765
2025
Q3 		$739K Sell
20,960
-246
-1% -$8.48K ﹤0.01% 1822
2025
Q2 		$695K Buy
21,206
+2,198
+12% +$71.4K ﹤0.01% 1780
2025
Q1 		$613K Buy
19,008
+3,291
+21% +$122K ﹤0.01% 1760
2024
Q4 		$480K Buy
15,717
+403
+3% +$13K ﹤0.01% 1909
2024
Q3 		$429K Buy
15,314
+130
+0.9% +$3.2K ﹤0.01% 1942
2024
Q2 		$346K Buy
15,184
+1,842
+14% +$42.5K ﹤0.01% 2221
2024
Q1 		$406K Buy
13,342
+422
+3% +$14.1K ﹤0.01% 2110
2023
Q4 		$461K Sell
12,920
-2,541
-16% -$94.5K ﹤0.01% 2032
2023
Q3 		$677K Sell
15,461
-25
-0.2% -$1.22K ﹤0.01% 1755
2023
Q2 		$764K Sell
15,486
-1,040
-6% -$47.9K ﹤0.01% 1724
2023
Q1 		$685K Sell
16,526
-4,083
-20% -$169K ﹤0.01% 1776
2022
Q4 		$915K Sell
20,609
-5,988
-23% -$250K ﹤0.01% 1596
2022
Q3 		$1.04M Buy
26,597
+1,574
+6% +$72K ﹤0.01% 1478
2022
Q2 		$1.02M Buy
25,023
+3,961
+19% +$188K ﹤0.01% 1535
2022
Q1 		$1.38M Buy
21,062
+185
+0.9% +$12K ﹤0.01% 1465
2021
Q4 		$1.45M Buy
20,877
+907
+5% +$65.9K ﹤0.01% 1445
2021
Q3 		$1.39M Sell
19,970
-247
-1% -$19K ﹤0.01% 1438
2021
Q2 		$1.6M Buy
20,217
+1,464
+8% +$106K ﹤0.01% 1405
2021
Q1 		$1.23M Buy
18,753
+12,114
+182% +$746K ﹤0.01% 1464
2020
Q4 		$370K Buy
6,639
+513
+8% +$22.2K ﹤0.01% 2026
2020
Q3 		$245K Buy
6,126
+841
+16% +$35.7K ﹤0.01% 2153
2020
Q2 		$238K Buy
+5,285
New +$230K ﹤0.01% 2095

Other funds holding ATRC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Nicholas Company
Nicholas Company Milwaukee, Wisconsin $5.45B AUM 19.89% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Lisanti Capital Growth
Lisanti Capital Growth New York $373M AUM 178.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Truist Financial's ATRC Position: Q3 2026 in Review

Truist Financial increased its AtriCure (ATRC) stake by 1.1% in Q3 2026, buying an estimated $11.1K and bringing the position to 21,791 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

Truist Financial first reported a position in ATRC in Q2 2020 and has held it in 26 quarters since. The position peaked at $1.6M in Q2 2021. 122 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Truist Financial held 21,791 shares of AtriCure worth $1.22M as of Q3 2026.
  • Truist Financial bought 246 AtriCure shares in Q3 2026, an estimated $11.1K.
  • AtriCure made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #1642 holding.
  • Truist Financial first reported a position in AtriCure in Q2 2020 and has held it in 26 quarters since.
  • Truist Financial's AtriCure position peaked at $1.6M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.